ELAROS Strengthens Ties with The University of Sheffield

The University of Sheffield logo 200x200
200 x 200px elaros logo

ELAROS is very pleased to be able to announce that Dr Sue Smith from the University of Sheffield has joined the Company on secondment as New Opportunities Manager. Sue’s focus with ELAROS will be to support the Company’s work with pharma companies by identifying and delivering opportunities through, for example, their open innovation schemes. 

Sue joins ELAROS under the University of Sheffield’s Pilot MRC Proximity to Discovery (P2D): Industry Engagement Scheme. 

Sue manages the Sheffield Healthcare Gateway in the Faculty of Medicine, Dentistry and Health and the small team of business managers developing translational, commercial and knowledge exchange projects with industry. Before taking up her position, Sue spent five years as a Research Translator in the Department of Biomedical Science, Sheffield, and has 7 years experience working in biotech firms in Germany and the US. 

Sue has a PhD from the European Molecular Biology Laboratory in Heidelberg and a BA (Hons) in Biochemistry from Oxford University. 

Sue’s specialties are: IP identification and development, business development, R&D and translational funding (MRC DPFS, MRC Confidence in Concept, Biomedical Catalyst, Wellcome Trust i4i, Wellcome Trust/Dept of Health – Health Innovation Challenge Fund), grant and proposal writing, project management, collaboration and relationship building, and facilitating knowledge exchange between academic and commercial sectors. 

Professor Paul O’Brien, CEO of ELAROS, said “I am delighted to be able to welcome Sue to the Team and I look forward to working with Sue over the coming months. Sue’s arrival at ELAROS represents an important development in the Company’s excellent relationship with the University of Sheffield”. 

Dr Sue Smith said “I am very pleased to have this excellent opportunity to work with ELAROS in a start-up environment involved in digital healthcare. It will be exciting to identify and develop new opportunities for the Company”.